Pro-generics Policies and the Backlog in Medicines Registration in South Africa: Implications for Access to Essential and Affordable Medicines
(2015; 9 pages)

Reprint with permission. Leng H, et al. Pro-generics policies and the backlog in medicines registration in South Africa: implications for access to essential and affordable medicines. Generics and Biosimilars Initiative Journal (GaBI Journal). 2015;4(2):58-63.

Resumen

The backlog in medicines registration in South Africa is a result of the implementation of pro-generics policies without strengthening the regulator to handle the substantial increase in registration applications that followed. Despite the backlog, more than enough generics are registered to promote price competition and ensure access to affordable medicines.

 
El Portal de Información - Medicamentos Esenciales y Productos de Salud de la OMS fue diseñado y es mantenido por la ONG Human Info. Última actualización: le 29 octubre 2018